MedTrace Logo

FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis

NCT00486798 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2010-12-10

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of quetiapine IR, following rapid titration versus conventional titration in patients with acute psychosis

Conditions

Interventions

DRUG

Quetiapine

PROCEDURE

Rating Scales

PROCEDURE

Self Assessment Form

PROCEDURE

Blood and urine samples

PROCEDURE

Sleeping pattern

Sponsors & Collaborators

Principal Investigators

  • Jaan Ruusa, MD,PhD · Huddinge Hospital Stockholm Sweden

  • Birgit Ekholm, MD · AstraZeneca Sweden AB

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00486798 on ClinicalTrials.gov